Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP100100451
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Engineering of composite particles to enhance performance in respiratory drug delivery. Respiratory conditions such as asthma and chronic pulmonary disease affect in excess of 5.8 million Australians and the common method of treatment is via drug inhalation. Although a wide range of drugs are commercially available as dry powder inhalers the efficiency of these systems is poor, with most devices delivering less than 20% to the lung. This project will develop a new method of high-efficiency respiratory drug delivery based on composite particles. The technology developed from this project will advance Australia’s Research & Innovation and Pharmaceutical industry sector, and improve healthcare outcomes in the government’s key priority area of Promoting and maintaining good health: ‘A healthy start to life’ and ‘Ageing well’Funded Activity Details
Start Date: 04-2011
End Date: 06-2015
Funding Scheme: Linkage Projects
Funding Amount: $335,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Pharmacology and Pharmaceutical Sciences | Pharmaceutical Sciences | Physical Chemistry of Materials | Chemical Sciences not elsewhere classified
ANZSRC Socio-Economic Objective (SEO)
Respiratory system and diseases (incl. asthma) | Public health not elsewhere classified | Treatments (e.g. chemicals, antibiotics) |
